Teleflex Announces ARROW EZ-IO Vascular Access System Reaches 3M Needles Sold Milestone

Teleflex Incorporated

, a leading global provider of medical devices for critical care and surgery, has announced that the ARROW® EZ-IO® Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014. “This is a significant milestone for the Arrow® EZ-IO® Vascular Access System because it demonstrates that IO is gaining acceptance for emergency and difficult vascular access,” said Jay White, President and General Manager, Vascular Access Division, Teleflex. “It demonstrates the lifesaving capabilities of the EZ-IO vascular Access System through its clinical benefits centered around ease of use, speed to vascular access, and safety.” The Arrow® EZ-IO® Vascular Access System is a safe, fast, effective vascular access option that provides peripheral venous access with central venous catheter performance. It's ideal for patients in whom peripheral vascular access is difficult or impossible in the hospital and pre-hospital setting. In a recent Huffington Post article profiling Dr. Suzanne Donovan, a physician traveling to Sierra Leone to fight the recent Ebola outbreak, intraosseous (IO) infusion was identified as one of the safest ways of providing fluids to patients who can't take oral fluids. Teleflex is proud to have supported Dr. Donovan's efforts with a donation. Teleflex will feature the ARROW® EZ-IO® Vascular Access System at the upcoming annual conferences for the American College of Emergency Physicians (ACEP) and EMS World Expo. Both conferences will feature educational cadaver labs that will provide a unique hands-on opportunity for participants to practice vascular access techniques as well as receive an in-depth review of associated anatomy on cadaveric specimens. ACEP 2014 will be held October 27-30 at the McCormick Convention Center, in Chicago, IL. EMS World Expo will be held November 9-13 at the Music City Center, in Nashville, TN. Potential complications with the ARROW® EZ-IO® Vascular Access System may include local or systemic infection, hematoma, extravasations, or any other complications associated with percutaneous insertion of sterile devices.